Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Adoption of Triple Combination Therapy Accelerates at Unprecedented Rates as Precision Medicine Revolution ContinuesRockville, MD, Jan. 29, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market ...

But GSK is only looking at the business Walmsley said the “we don’t need it and we won’t overpay for it," - and also pledged that its most important division, pharma, would not lose out on ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including sig ...

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

The "Abbott Elementary" actor also shared words of encouragement she received from Cicely Tyson, Maya Angelou and Sidney ...

“Measles is the most contagious of the vaccine-preventable diseases. If you are sick with COVID, and you go about your normal ...

As of 11:22:43 AM GMT+5:30. Market Open.

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...